Constructions of eukaryotic expression vector of sense and antisense VEGF165 and its expression regulation

World Chinese Journal of Digestology

Volumn 9, Issue 8, 2001, Pages 886-891

  Liu, D H ^a   Zhang, W ^a   Su, Y P ^a   Zhang, X Y ^a   Huang, Y X ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial growth factor genetics; Endothelium; Gene expression; Genetic vectors; Stomach neoplasms genetics; Stomach neoplasms pathology; Transfection; Vascular cytology

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RECOMBINANT VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RECOMBINANT DNA TECHNOLOGY; STOMACH CANCER;

EID: 0034882363     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
2. Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products
3. Significance of vascular endothelial growth factor messenger RNA expression in gastric cancer
4. Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension
5. 121 in gastric carcinoma MGC803 cell line
6. Vascular endothelial growth factor is a secreted angiogenic mitogen
7. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
8. Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice
9. Prevention of metastasis to liver by using 5-FU intraperitoneal chemotherapy in nude mice inoculated with human colonic cancer cells
10. Significance of microvessel count in gastric carcinoma
11. Expression of vascular endothelial growth factor and its prognostic significance in gastric carcinoma
12. Morphological analysis of lymph vessels and capillaries in gastric carcinoma
13. Overproduction of nitric oxide inhibits vascular reactivity in portal hypertensive rats
14. A pathologic analysis of 4451 cases with digestive tract cancer
15. Gene expression of hepatocyte growth factor ant its receptor in HCC and nontumorous liver tissues
16. Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients
17. Measurements of cell proliferation in esophageal and gastric cardia epithelia of subjects in a high incidence area for esophageal cancer
18. P53 and PCNA expression in glandular dilatation of gastric mucose
19. Quantitative ultrastructure analysis of neuroendocrine cells of gastric mucose in normal and pathological conditions
20. Ultrastructural enzyme cytochemical study on signet-ring cells of gastric cancer
21. Pituitary follicular cells secrete an novel heparin-binding growth factor specific for vascular endothelial cells
22. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
23. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo
24. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors distribution of VEGF protein and possible in vivo regulatory mechanisms
25. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
26. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors concentration in tumor blood vessels
27. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia
28. Gene transfer of vascular endothelial growth factor plasmid/liposome complexes in glioma cells in vitro: The implication to the treatment of cerebral ischemic diseases
29. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia
30. Surgical and percutaneous myocardial angiogenesis induction. Part II neoangiogenesis
31. Gene-therapy for peripheral vascular diseases
32. Loss of heterozygosity and mRNA expression at DCC locus in gastric cancer
33. A preliminary study on the loss of heterozygosity at 17p13 in gastric and colorectal cancers
34. Clinicopathologic risk factors and prognostic evaluation in hepatocellular carcinoma recurrence after surgery
35. CEA and AFP expression in human hepatoma cells transfected with antisense IGF-I gene
36. Current status of gene therapy in gastroenterology
37. Molecular biology and the diagnosis and treatment of liver diseases
38. Tumor growth inhibition effect of hIL-6 on colon cancer cells transfected with the target gene by retroviral vector
39. Inhibitory effect of IGF-II antisense RNA on malignant phenotype of hepatocellular carcinoma
40. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon spiking
41. Anti-angiogenesis: New concept for therapy of solid tumors
42. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
43. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
44. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells
45. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro
46. The short form of the alternatively spliced fit-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers
47. 1, and tissue factor and also cell growth and invasion activities
48. Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor
49. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α→ hypoxia response element→ VEGF cascade differentially regulates vascular response and growth rate in tumors
50. 3 signal peptide
51. The antisense gene of growth factor receptor reversing the malignant phenotype of human hepatoma cells
52. Progress in studies of inhibiting hepatitis virus by antisense oligodeoxynucleotide
53. Growth inihbition of human gastric carcinoma cells by DNA polymerase a antisense oligodeoxynucleotide
54. Inhibitory effects of EGFR antisense oligodeoxynucleotide with liposome in human colorectal cancer cell line
55. Construction of pIGF-II As: A eukaryotic expression vector for antisense human insulin-like growth factor II gene
56. Adenoassociated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
57. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: Effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts
58. Adventitial gene transfer to arterial wall
59. Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma
60. Local drug delivery and gene therapy
61. Oligodeoxynudeotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
62. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
63. VEGF-mediated tumour angiogenesis: A new target for cancer therapy
64. Therapeutic angiogenesis: A case for targeted, regulated gene delivery
65. Therapeutic interventions for enhancing collateral development by administration of growth factors: Basic principles, early results and potential hazards
66. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: Anesthetic management and results
67. Gene therapy with VEGF
68. Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease
69. Amelioration of microvascular myocardial ischemia by gene transfer of vascular endothelial growth factor in rabbits